leadf
logo-loader
viewRegeneus Ltd

Regeneus Ltd with Proactive at the ASX Small and Mid-Cap Conference 2020

Regeneus Ltd's (ASX:RGS) Leo Lee speaks to Proactive's Andrew Scott while at the virtual ASX Small and Mid-Cap Conference 2020. They're an Australian biotech looking to improve the quality of life for patients suffering from pain. It develops regenerative medicine products that interrupt the inflammatory cascade that leads to pain.

Quick facts: Regeneus Ltd

Price: 0.12 AUD

ASX:RGS
Market: ASX
Market Cap: $36.03 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Empress Royalty: A majestic portfolio of precious metal opportunities

Empress Royalty Corp (CVE:EMPR) is analysed by Proactive mining expert Dr. Ryan Long who takes viewers through the detail on the latest mining royalty and streaming company to come to the market. After listing on the TSX-V in December 2020, express offers investors exposure to a precious...

43 minutes ago

2 min read